[The role of the system of reverse capture of dopamine in the development of experimental Parkinsonism under the effect of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine and its pyridine analogs].
Bachurin
S O
SO
Soliakov
L S
LS
Lermontova
N N
NN
Tkachenko
S E
SE
Kalashnikov
V V
VV
Serkova
T P
TP
Petrova
L N
LN
D015632:1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine / Q000494:pharmacology*; D000818:Animals; D001679:Biogenic Amines / Q000378:metabolism; D001921:Brain / Q000378:metabolism; D055598:Chemical Phenomena; D002621:Chemistry; D004298:Dopamine / Q000378:metabolism*; D051379:Mice; D008810:Mice, Inbred C57BL; D010302:Parkinson Disease, Secondary / Q000378:metabolism*; D013574:Synaptosomes / Q000378:metabolism
D001679:Biogenic Amines; D015632:1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; D004298:Dopamine
Rol' sistemy obratnogo zakhvata dofamina v razvitii éksperimental'nogparkinsonizma pod deĭstviem 1-metil-4-fenil-1,2,5,6-tetragidropiridin i ego piridinovykh analogov.